Cadre Holdings, Inc.
CDRE- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001860543
In the last 90 days, Cadre Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $944.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cadre Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $9.47M in total
- Insiders trading
- 2
- Net value
- −$9.47M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cadre Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kanders Warren B | CEO AND CHAIRMAN | 9,417,039Indirect | Aug 26, 2026 | 11 |
| Williams Brad | PRESIDENT | 65,081 | Aug 19, 2026 | 9 |
| Sokolow Nicolas | Director | 79,231Indirect | Jun 18, 2026 | 1 |
| Quigley William G III | Director | 23,500 | Jun 18, 2026 | 1 |
| Norton Hamish | Director | 23,500 | Jun 18, 2026 | 1 |
| Browers Blaine | CHIEF FINANCIAL OFFICER | 69,653 | Jun 18, 2026 | 5 |
| Kissel Mary E. | Director | – | Jun 18, 2026 | 1 |
| DeCotis Deborah A | Director | – | Jun 3, 2025 | 0 |
| Delzanno Gianmaria C | Director | – | Jun 3, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 (view filing) | Dec 20 | 2 days | Sokolow NicolasDirector | SSaleCommon Stock, $.0001 par value ("Common Stock") | −316 | $21.60 | −$6.83K | −0.3%125.3K after | |
| Dec 22, 2022 (view filing) | Dec 21 | 1 day | Sokolow NicolasDirector | SSale | −100 | $21.10 | −$2.11K | −0.1%125.2K after | |
| Dec 16, 2022 (view filing) | Dec 14 | 2 days | Sokolow NicolasDirector | SSaleCommon Stock, $.0001 par value ("Common Stock") | −5.44K | $21.99 | −$119.7K | −4.2%125.6K after | |
| Dec 14, 2022 (view filing) | Dec 12 | 2 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −13.0K | $22.12 | −$287.4K | −0.1%15.8M after | |
| Dec 14, 2022 (view filing) | Dec 13 | 1 day | Kanders Warren BCEO AND CHAIRMAN | SSale | −6.27K | $22.10 | −$138.5K | 0.0%15.8M after | |
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Sokolow NicolasDirector | SSaleCommon Stock, $.0001 par value ("Common Stock") | −100 | $23.50 | −$2.35K | −0.1%133.5K after | |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Sokolow NicolasDirector | SSale | −2.50K | $22.10 | −$55.3K | −1.9%131.0K after | |
| Dec 9, 2022 (view filing) | Dec 7 | 2 days | Sokolow NicolasDirector | SSaleCommon Stock, $.0001 par value ("Common Stock") | −2.46K | $23.98 | −$58.9K | −1.8%134.9K after | |
| Dec 9, 2022 (view filing) | Dec 8 | 1 day | Sokolow NicolasDirector | SSale | −1.25K | $23.26 | −$29.1K | −0.9%133.6K after | |
| Dec 9, 2022 (view filing) | Dec 7 | 2 days | Kanders Warren BCEO AND CHAIRMAN | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −25.4K | $23.63 | −$599.9K | −0.2%15.8M after |